Subsequent hematopoietic stem cell transplantation (HSCT) associated with longer survival in patients with relapsed/refractory (R/R) acute myelogenous leukemia (AML) after clo+ara-c or ara-c alone: a landmark analysis from the classic I trial

Authors
Category Primary study
Conference3rd International Cancer Research Symposium: Defining & Translating Science for Disease Prevention and Therapy; 2012 Dec 18-21; Kolkata, West Bengal, India. Journal of Cell Communication and Signaling
Year 2013
This article has no abstract
Epistemonikos ID: 9dee218bddf5ce5c8c26aa76c0ce2061f5c03ccd
First added on: Jan 21, 2022